Biomarker may guide chemo choices for pancreatic cancer patients
NCT ID NCT04472910
First seen Mar 19, 2026 · Last updated May 16, 2026 · Updated 11 times
Summary
This study looks at whether a biomarker called GATA6 can help predict how well chemotherapy works for people with pancreatic cancer that can be surgically removed. About 84 participants will receive chemotherapy before and after surgery, and researchers will measure their GATA6 levels to see if it relates to how long they stay cancer-free. The goal is to move toward personalized treatment strategies instead of a one-size-fits-all approach.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESECTABLE PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
BC Cancer Agency Vancouver
Vancouver, British Columbia, Canada
-
Jewish General Hospital
Montreal, Quebec, Canada
-
Kingston Health Sciences Centre
Kingston, Ontario, Canada
-
London Health Sciences Centre
London, Ontario, Canada
-
Ottawa Hospital
Ottawa, Ontario, Canada
-
Princess Margaret Cancer Centre
Toronto, Ontario, M5G 2N9, Canada
-
Sunnybrook Hospital/Odette Cancer Centre
Toronto, Ontario, Canada
-
Unity Health (St. Joseph's and St. Michael's)
Toronto, Ontario, Canada
Conditions
Explore the condition pages connected to this study.